Gilead nears deal to buy Immunomedics for more than US$20 billion: Report

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

Gilead to buy Immunomedics in a US$21 billion deal

LONDON: Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than US$20 billion in a deal that would further expand Gilead's portfolio of cancer treatments, the Wall Street Journal reported on Saturday .

A deal for Immunomedics, whose cancer therapy Trodelvy is FDA-approved as a third-line treatment for an aggressive type of breast cancer called Metastatic Triple-Negative Breast Cancer, could be announced Monday if not sooner, the Journal said, citing people familiar with the matter.Discussions between Gilead and Immunomedics were initially centered around a partnership before shifting to a full-fledged takeover negotiation, the Journal added.

An acquisition of Immunomedics would add to several deals Gilead inked this year with the aim of expanding its oncology portfolio.It bought a 49.9 per cent stake in cancer drug developer Pionyr Immunotherapeutics in June for US$275 million, just months after paying US$4.9 billion for Forty Seven Inc, maker of an experimental treatment that targets blood cancer.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Gilead nears deal to buy Immunomedics for more than US$20 bln -WSJGilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than US$20 billion, the Wall Street Journal ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Gilead nears deal to buy Immunomedics for more than US$20 bln -WSJGilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than US$20 billion, the Wall Street Journal ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Nvidia nears deal to buy chip designer Arm for more than US$40 billion - sourcesNvidia Corp is close to a deal to buy British chip designer Arm Holdings from SoftBank Group Corp for more than US$40 billion (£31.26 billion) ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

SoftBank nears deal to sell Arm Holdings to Nvidia for more than US$40 billionSoftBank Group Corp is nearing a deal to sell British chip designer Arm Holdings to Nvidia Corp for more than US$40 billion, the Wall Street ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

SoftBank nears deal to sell Arm Holdings to Nvidia for more than US$40 bln - WSJSoftBank Group Corp is nearing a deal to sell British chip designer Arm Holdings to Nvidia Corp for more than US$40 billion, the Wall Street ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

SoftBank said to near a deal to sell British chip designer Arm[LONDON] SoftBank is near a deal to sell British chip designer Arm to Nvidia, two people briefed on the matter said Saturday, which would raise billions for the Japanese technology investor and create a powerhouse in the semiconductor industry. Read more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »